Madrigal Pharmaceuticals, Inc.
Ticker: MDGL
| Insider | Title |
|---|---|
| Alex G. Howarth | Chief Financial Officer |
| Brian Joseph Lynch | SVP and General Counsel |
| Bros. Advisors (gp) Llc Baker | Director |
| Bros. Advisors Lp Baker | Director |
| Brothers Life Sciences Lp Baker | Director |
| Carole Huntsman | Chief Commercial Officer |
| City Capital Fund Iv Co Invesment Fund Lp Bay | 10% or greater ownership |
| City Capital Fund Iv, L.p. Bay | 10% or greater ownership |
| City Capital Llc Bay | 10% or greater ownership |
| City Capital Management Iv Llc Bay | 10% or greater ownership |
| David V Milligan | Director |
| Felix Baker | Director |
| Fred B Craves | Director |
| James M Daly | Director |
| Julian Baker | Director |
| Keith R Gollust | Director |
| Kenneth Bate | Director |
| L.p. 667, | Director |
| Mardi Dier | SVP and CFO |
| Paul A Friedman | Director |
| Rebecca Taub | Pres., RD, and CMO, Director |
| Remy Sukhija | Chief Commercial Officer |
| Richard S Levy | Director |
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. |
| Shannon T Kelley | General Counsel |
| William John Sibold | President and CEO, Director |